Descriptor English: | Dysbindin | ||||||
Descriptor Spanish: |
Disbindina
| ||||||
Descriptor Portuguese: | Disbindina | ||||||
Descriptor French: | Dysbindine | ||||||
Entry term(s): |
DTNBP1 Protein Dysbindin 1 Dysbindin-1 Dystrobrevin Binding Protein 1 Hermansky Pudlak Syndrome 7 Protein Hermansky-Pudlak Syndrome 7 Protein |
||||||
Tree number(s): |
D12.776.210.500.410.250 D12.776.220.362.125 D12.776.543.268.250 D12.776.543.990.447 D12.776.631.262 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000074765 | ||||||
Scope note: | A dystrophin-associated protein and component of the Biogenesis of Lysosomal Organelles Complex-1 (BLOC-1 complex) which is essential for the formation of LYSOSOME - derived organelles such as platelet dense granules and MELANOSOMES. DTNBP1 is expressed primarily in the brain and neurons, where it functions with ADAPTOR PROTEIN COMPLEX 3 to transport membrane proteins to NEURITES and nerve terminals. It also regulates the release of neurotransmitters, transport of synaptic vesicles, and localization of DOPAMINE D2 RECEPTORS. Mutations in the DTNBP1 gene are associated with Type 7 HERMANSKY-PUDLAK SYNDROME and SCHIZOPHRENIA. |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Previous Indexing: |
Dystrophin-Associated Proteins (2001-2017) |
||||||
Public MeSH Note: | 2018 |
||||||
History Note: | 2018 |
||||||
DeCS ID: | 57103 | ||||||
Unique ID: | D000074765 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2018/01/01 | ||||||
Date of Entry: | 2017/07/11 | ||||||
Revision Date: | 2017/04/05 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Dysbindin
- Preferred
Concept UI |
M000627424 |
Scope note | A dystrophin-associated protein and component of the Biogenesis of Lysosomal Organelles Complex-1 (BLOC-1 complex) which is essential for the formation of LYSOSOME - derived organelles such as platelet dense granules and MELANOSOMES. DTNBP1 is expressed primarily in the brain and neurons, where it functions with ADAPTOR PROTEIN COMPLEX 3 to transport membrane proteins to NEURITES and nerve terminals. It also regulates the release of neurotransmitters, transport of synaptic vesicles, and localization of DOPAMINE D2 RECEPTORS. Mutations in the DTNBP1 gene are associated with Type 7 HERMANSKY-PUDLAK SYNDROME and SCHIZOPHRENIA. |
Preferred term | Dysbindin |
Entry term(s) |
DTNBP1 Protein Dysbindin 1 Dysbindin-1 Dystrobrevin Binding Protein 1 Hermansky Pudlak Syndrome 7 Protein Hermansky-Pudlak Syndrome 7 Protein |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey